Literature DB >> 2494326

Plasma and lipoprotein lipids and apolipoproteins AI, AII and B in patients with chronic airflow limitation.

C H Bolton1, E Mulloy, J Harvey, L G Downs, M Hartog.   

Abstract

Plasma and lipoprotein cholesterol and triglycerides, and plasma apolipoproteins AI, AII and B were compared in patients with chronic airflow limitation, and normal controls matched for body mass index. The controls were non-smokers, and free from respiratory disease. High-density lipoprotein (HDL) cholesterol concentration was significantly elevated in the patients, due mainly to a raised HDL2 cholesterol level. HDL triglyceride was significantly lower in the patients. All other lipids were not different from normal. Apolipoprotein AI levels were significantly raised in the patients but other apolipoproteins were unchanged. The changes found may account in part for the fact that patients with chronic airflow limitation have a lower incidence of atherosclerotic heart disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2494326      PMCID: PMC1292001          DOI: 10.1177/014107688908200212

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  14 in total

1.  Efficiency of case-control studies with multiple controls per case: continuous or dichotomous data.

Authors:  H K Ury
Journal:  Biometrics       Date:  1975-09       Impact factor: 2.571

2.  MYOCARDIAL INFARCTION IN RESPIRATORY INSUFFICIENCY.

Authors:  P M NONKIN; M M DICK; G L BAUM
Journal:  Arch Intern Med       Date:  1964-01

3.  Terbutaline raises high-density-lipoprotein-cholesterol levels.

Authors:  P L Hooper; W Woo; L Visconti; D R Pathak
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

4.  Increased high density lipoprotein cholesterol in obstructive pulmonary disease (predominant emphysematous type).

Authors:  G M Tisi; A Conrique; E Barrett-Connor; S M Grundy
Journal:  Metabolism       Date:  1981-04       Impact factor: 8.694

5.  Immunonephelometry of apolipoprotein A-II in plasma.

Authors:  M Rosseneu; N Vinaimont; T A Musliner; D Bernier; P N Herbert; F Belpaire
Journal:  Clin Chem       Date:  1984-02       Impact factor: 8.327

6.  Cholesterol determination in high-density lipoproteins separated by three different methods.

Authors:  M F Lopes-Virella; P Stone; S Ellis; J A Colwell
Journal:  Clin Chem       Date:  1977-05       Impact factor: 8.327

7.  A micro-method for the rapid ultracentrifugal separation of human plasma high density lipoprotein subfractions, HDL2 and HDL3.

Authors:  J Eyre; F Hammett; N E Miller
Journal:  Clin Chim Acta       Date:  1981-08-10       Impact factor: 3.786

Review 8.  Some considerations of methodology and standardization of apolipoprotein B immunoassays.

Authors:  M Rosseneu; R Vercaemst; K K Steinberg; G R Cooper
Journal:  Clin Chem       Date:  1983-03       Impact factor: 8.327

9.  Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins.

Authors:  N E Miller; F Hammett; S Saltissi; S Rao; H van Zeller; J Coltart; B Lewis
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-30

Review 10.  Some considerations of methodology and standardization of apolipoprotein A-I immunoassays.

Authors:  K K Steinberg; G R Cooper; S R Graiser; M Rosseneu
Journal:  Clin Chem       Date:  1983-03       Impact factor: 8.327

View more
  2 in total

1.  Relationships among smoking habits, airflow limitations, and metabolic abnormalities in school workers.

Authors:  Masafumi Horie; Satoshi Noguchi; Wakae Tanaka; Yasushi Goto; Hisanao Yoshihara; Masaki Kawakami; Masaru Suzuki; Yoshio Sakamoto
Journal:  PLoS One       Date:  2013-11-29       Impact factor: 3.240

2.  Tobacco Smoke Exposure Reduces Paraoxonase Activity in a Murine Model.

Authors:  Robert M Reed; Saif M Borgan; Michael Eberlein; Monica Goldklang; Joshua Lewis; Michael Miller; Mohamad Navab; Bo S Kim
Journal:  Int J Biomed Sci       Date:  2017-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.